BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$467M |
| 2 |
Alibaba
BABA
|
+$273M |
| 3 |
Citigroup
C
|
+$263M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$123M |
| 5 |
Ambev
ABEV
|
+$93.4M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.35B |
| 2 |
Apple
AAPL
|
+$300M |
| 3 |
Bank of America
BAC
|
+$272M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Amazon
AMZN
|
+$235M |
Sector Composition
| 1 | Financials | 12.19% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 10.11% |
| 4 | Communication Services | 9.76% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLBL
2601
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
| $56.9K | ﹤0.01% |
11,264
+11,086
| +6,228% | +$56K |
|
2602
Shopify
SHOP
$186B
| $56.8K | ﹤0.01% |
6,540
-4,900
| -43% | -$42.6K |
|
2603
DHI Group
DHX
$141M
| $56.8K | ﹤0.01% |
19,920
+9,479
| +91% | +$27K |
|
2604
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $56.6K | ﹤0.01% |
3,943
+3,837
| +3,620% | +$55.1K |
|
|
OME
2605
DELISTED
Omega Protein
OME
| $56.6K | ﹤0.01% |
3,160
+842
| +36% | +$15.1K |
|
2606
Midland States Bancorp
MSBI
$385M
| $56.5K | ﹤0.01% |
1,686
+1,653
| +5,009% | +$55.4K |
|
|
HTB
2607
HomeTrust Bancshares, Inc.
HTB
$713M
| $56.4K | ﹤0.01% |
2,312
+2,106
| +1,022% | +$51.4K |
|
2608
Regenxbio
RGNX
$465M
| $56.3K | ﹤0.01% |
2,853
+2,023
| +244% | +$40K |
|
|
EGC
2609
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
| $56.3K | ﹤0.01% |
+3,032
| New | +$56.3K |
|
2610
Aclaris Therapeutics
ACRS
$211M
| $55.9K | ﹤0.01% |
2,062
+2,037
| +8,148% | +$55.2K |
|
|
UN
2611
DELISTED
Unilever NV New York Registry Shares
UN
| $55.8K | ﹤0.01% |
1,009
| – | – |
|
|
ASCMA
2612
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $55.6K | ﹤0.01% |
3,619
+1,089
| +43% | +$16.7K |
|
2613
Acushnet Holdings
GOLF
$4.38B
| $55.2K | ﹤0.01% |
2,781
+2,410
| +650% | +$47.8K |
|
2614
Harmony Gold Mining
HMY
$9.34B
| $55.2K | ﹤0.01% |
33,429
-74,715
| -69% | -$123K |
|
|
LJPC
2615
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $55.1K | ﹤0.01% |
1,852
+1,784
| +2,624% | +$53.1K |
|
|
ITCI
2616
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $55.1K | ﹤0.01% |
4,439
+3,683
| +487% | +$45.7K |
|
|
REV
2617
DELISTED
Revlon, Inc.
REV
| $55.1K | ﹤0.01% |
2,323
+1,661
| +251% | +$39.4K |
|
|
ROCC
2618
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $54.9K | ﹤0.01% |
+1,495
| New | +$54.9K |
|
2619
Heritage Commerce
HTBK
$624M
| $54.9K | ﹤0.01% |
3,983
+3,806
| +2,150% | +$52.4K |
|
2620
Alpha and Omega Semiconductor
AOSL
$853M
| $54.9K | ﹤0.01% |
3,291
+1,586
| +93% | +$26.4K |
|
|
PDLI
2621
DELISTED
PDL BioPharma, Inc.
PDLI
| $54.8K | ﹤0.01% |
22,166
+18,478
| +501% | +$45.6K |
|
|
TBHC
2622
The Brand House Collective, Inc. Common Stock
TBHC
$53.2M
| $54.6K | ﹤0.01% |
5,315
+2,334
| +78% | +$24K |
|
2623
Nicolet Bankshares
NIC
$2B
| $54.1K | ﹤0.01% |
989
+931
| +1,605% | +$50.9K |
|
2624
UBS Group
UBS
$129B
| $54.1K | ﹤0.01% |
3,186
-9,162
| -74% | -$156K |
|
2625
TG Therapeutics
TGTX
$5.1B
| $54.1K | ﹤0.01% |
5,381
+5,066
| +1,608% | +$50.9K |
|